The neurofeedback systems market is set to reach from US$ 820.7 Mn in 2017 to US$ 1,565.6 Mn by 2026 at a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2018 to 2026. According to the latest research findings published in Lancet by the Global Burden of Disease (GBD), neurological disease are the leading cause of death and disability worldwide. Neurofeedback system is also called as EEG biofeedback system is a noninvasive type of brain training system. It employs electrodes to record and modulate brain waves in the treatment of neurological diseases.

"Simplicity and popularity among neurologist drives the market growth for frequency neurofeedback system"

Frequency neurofeedback system is currently reigning the type segment for neurofeedback systems market. The key features contributing to its positive growth are its ease and simplicity to operate and popularity among neurologist. It uses 2 to 4 surface electrodes and so is popularly called as surface neurofeedback. It is employed to change the speed and amplitude of specific brain waves for the treatment of neurological disorders such as ADHD, insomnia and anxiety. Functional magnetic resonance imaging (fMRI) is the latest neurofeedback system which is employed to modulate brain activity from deep subcortical brain region. It is the most effective method used in the planning and execution of epilepsy surgery.

"Increasing prevalence rate and significant rise in the patients showing resistance to medication drive the market growth for epilepsy"

Epilepsy is currently dominating the application segment for neurofeedback systems market. 50 million people throughout the globe are suffering with epilepsy making it the most common neurological disease. It causes social discrimination and stigma to people suffering with epilepsy. There has been a significant increase in the number of patients showing resistance to medication. In epilepsy the brain continuously misfires signals, hence neurofeedback modulates the brain to inhibit slow waves and promote mid-range frequencies which eventually prevents seizures. Attention deficit hyperactivity disorder (ADHD) has garnered a lot of attention in the last decade. Medications such as Concerta, Ritalin and Dexedrine have been used as long term treatment for ADHD, evidence have reported with severe adverse effects associated with this medication such as anxiety, insomnia and decreased appetite. Neurofeedback therapy decreases the brain activity in theta band region and promotes activity in beta band region in patients suffering with ADHD.

"Rising prevalence of neurological disorders and existence of advanced healthcare infrastructure drive the market growth in North America"

North America currently holds a share of 60% in the neurofeedback systems market. The major features responsible for its dominance in global neurofeedback systems market are rising prevalence of neurological disorders and existence of advanced healthcare infrastructure. As per the statistics provided by Center for Disease Control and Prevention (CDC), there are approximately 3.4 million U.S. citizens suffering with active epilepsy. Europe is the second largest market with a share of 20% on account of large population base suffering with insomnia and anxiety. Several patients are showing resistance to medication and are seeking EEG based therapies to change the brainwaves to counteract ADHD, epilepsy and migraine. Asia Pacific represents a share of 8% and is set to register impressive growth during the forecast period from 2018 to 2026 on account of developing health infrastructure and rampant growth in neurological diagnosis and treatment.

Medical device manufacturers producing EEG equipment for neurofeedback systems are BrainMaster Technologies, Inc., BEE Medic GmbH, Mind Media B.V., Mitsar Co., Ltd., Myndlift, Neurobit Systems, NeuroCare Group GmbH, Stens Corporation, Thought Technology Ltd. and Wearable Sensing.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Neurofeedback Systems market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Neurofeedback Systems market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Neurofeedback Systems market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Neurofeedback Systems market?
• Which is the largest regional market for Neurofeedback Systems market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Neurofeedback Systems market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Neurofeedback Systems market worldwide?